2027 Star Ratings Are Confirmed: Reading the Official Numbers for Q4 UM Work

CMS released the official 2027 Star Ratings on October 8: 188 of 508 rated MA-PD contracts earned at least four stars, while approximately 71% of MA-PD enrollees are in those contracts. The enrollment-weighted average is 3.99. For physician advisors, the next step is contract-specific review of published ratings and relevant appeals and care-transition measures, not a different coverage standard for a current authorization.

the-advisor
10-12-2026

On 10-08-2026, CMS released the official 2027 Medicare Advantage and Part D Star Ratings. The numbers are now confirmed, not projected. For physician advisors and utilization review leaders, the release moves the relevant question from "what might happen" to "here is the actual contract performance data on the plans you work with every day."

This article is a companion to the analysis published earlier this month on what the October 8 release was expected to set in motion. That piece covered the structure: what star ratings determine, what the 4.0-star quality bonus threshold means, and what ratings do not change about current coverage standards. This piece covers what the confirmed data shows and how to apply it operationally in Q4.

What the Confirmed Distribution Shows

CMS counted 508 MA-PD contracts in the 2027 ratings cycle. The confirmed breakdown by rating tier is as follows:

  • 5.0 stars: 15 contracts
  • 4.5 stars: 65 contracts
  • 4.0 stars: 108 contracts
  • 3.5 stars: 164 contracts
  • 3.0 stars: 124 contracts
  • 2.5 stars: 31 contracts
  • 2.0 stars: 1 contract

188 contracts (37%) earned four stars or above. 320 contracts (63%) are below the 4.0-star quality bonus threshold. The enrollment-weighted average across all rated contracts is 3.99, down slightly from the prior cycle. The enrollment-weighted figure differs from a simple contract average because larger, higher-enrollment contracts tend to perform above the contract-count midpoint.

The enrollment-weighted picture is also different from the raw contract count on quality bonus coverage. Approximately 71% of MA-PD enrollees are currently in contracts rated four stars or above. That means the majority of beneficiaries are in plans that retain quality bonus eligibility for 2028, even though the majority of contracts by count do not.

Four MA-PD contracts carry CMS's low-performing icon for 2027. The designation reflects consistently low Part C and/or Part D performance under CMS's rules and should not be confused with the much broader group of contracts below the four-star bonus threshold.

How to Use the Confirmed Data

The CMS plan performance data tables, released alongside the October 8 fact sheet, contain contract-level ratings and measure-level data for every rated MA-PD plan. The Technical Notes, published separately, describe the methodology underlying the ratings. For contract-specific review, use the data tables for the actual rating values and the Technical Notes to understand how each measure was calculated for that cycle.

Physician advisors and UR leaders working with specific MA contracts can identify exactly where those contracts landed. The most operationally relevant data is not just the overall rating but the measure-level performance within the contract, particularly in categories that touch the advisor's daily work.

For physician advisors, the appeals measures deserve particular attention. CMS's 2027 methodology includes completeness checks on Independent Review Entity data for appeals-timeliness and appeals-review measures, with scaled reductions applied where data-integrity issues were identified. A low measure rating in the appeals category is a reason to examine the contract's published performance data and the applicable methodology, not proof that a particular denial was improper.

Measures addressing transitions of care, follow-up after emergency department visits for people with multiple high-risk chronic conditions, and access to needed care are also closer to the advisor's operational domain than a general review of overall rating tiers.

The 164 Contracts at 3.5 Stars

The most operationally significant tier in the confirmed distribution is the 164 contracts rated at 3.5 stars. These contracts sit below the 4.0-star quality bonus threshold. Below-threshold status has financial consequences: those contracts do not qualify for the quality bonus payment in 2028 and carry a lower rebate percentage than four-star or above contracts.

Not every contract at 3.5 stars crossed downward from four stars in this cycle. Some may have been at 3.5 stars in the prior cycle as well. The relevant question for each contract is what its rating was in the 2026 cycle and what the movement, if any, was. A contract that dropped from 4.0 to 3.5 stars has a different financial posture than one that has been at 3.5 stars for multiple cycles.

Plans in either position are not necessarily taking clinical policy action in Q4 2026. The coverage standards that govern current authorization decisions come from Medicare statutes, regulations, and the plan's published clinical policies, not from star rating position. Physician advisors should expect increased plan outreach on care-gap closure, documentation completeness, and chronic disease management in the coming months, because those activities affect 2027 HEDIS measurement for the ratings cycle that will determine 2029 quality bonus eligibility. That is quality improvement activity, not a change in coverage criteria.

AEP Starts October 15

Annual Enrollment Period opens 10-15-2026, and the confirmed Star Ratings are visible on Medicare Plan Finder for beneficiaries comparing plans. A contract below four stars carries that mark through AEP.

For advisors who work with patients during care transitions, the AEP question is whether specific plans are communicating service area exits, network changes, or benefit restructuring for 2027. Check Annual Notices of Change, nonrenewal notices, Evidence of Coverage documents, provider directories, and formal provider communications, as applicable. Verify the specific patient's expected coverage rather than infer a transition from the contract's rating position alone.

What the Confirmed Ratings Do Not Change

The October 8 release does not amend any National Coverage Determination, Local Coverage Determination, or clinical criteria in any plan's published medical policy. The coverage standard for an individual authorization comes from Medicare statutes, regulations, applicable coverage determinations, and the plan's published clinical criteria. A contract's star rating is not part of that analysis.

Plans may respond to rating position through benefit design, quality improvement programs, documentation and gap-closure outreach, and bid strategy. A rating change does not authorize a different coverage standard for a pending review. If you observe a practice pattern that appears inconsistent with applicable coverage criteria, the path is the same as it has always been: document the clinical basis, follow the appeals process, and cite the applicable coverage rules.

When monitoring published plan communications for actual clinical policy updates, a documented change should be evaluated against applicable Medicare requirements and the patient's circumstances. Publication alone does not establish that a criterion is compliant or properly applied.


Sources: CMS, "2027 Medicare Advantage and Part D Star Ratings," Fact Sheet, 10-08-2026 (cms.gov); Rise Health, "2027 Star Ratings Results: Average Holds, Carriers Diverge" (risehealth.org); Fierce Healthcare, "CMS releases the 2027 Medicare Advantage star ratings" (fiercehealthcare.com).

Transforming Healthcare with AI Technology

Discover how Addie helps health systems, post-acute providers, and payers improve throughput, reduce avoidable days, and deliver better transitions of care.

Get Started